NFI patients display CNS abnormalities including learning disabilities, clumsiness, astrocytomas, and abnormalities on magnetic resonance imaging exams. To determine whether the cellular and neuroanatomical distribution of neurofibromin reveals possible function for neurofibromin in the brain, we stained rat brain tissue sections with anti-neurofibromin antibodies.
Neurofibromin is highly enriched in large projection neurons, such as cortical and hippocampal pyramidal cells and cerebellar Purkinje cells. Neurofibromin is present in cell bodies and in axons, but is highly enriched in dendrites. lmmunoelectron microscopic analysis demonstrates that NFl is associated with smooth vesiculotubular elements and cisternal stacks and with multivesicular bodies in the cell body and dendrites, but not with the plasma membrane, nucleus, nuclear envelope, Golgi apparatus, mitochondria, or rough endoplasmic reticulum. The preferential localization of neurofibromin to the smooth endoplasmic reticulum, together with evidence that neurofibromin modulates ras GTPase activity, suggests that some, if not all, of the CNS manifestations of NFI might result from the altered expression of neurofibromin in neurons, perhaps through disruption of Caz+ signaling, translocation of organelles, or endocytic pathways.
[Key words: ras, Purkinje cell, pyramidal cell, learning disability, motor disorders, cisternal stacks, smooth endoplasmic reticulum, calcium, microtubules, organelle movement] Von Recklinghausen's neurofibromatosis (NFl) is an autosomal dominantly inherited disorder that affects 1 in 3500 humans (Riccardi, 198 1; Eldridge et al., 1989) . Although the most frequently reported abnormalities involve derivatives of the neural crest, a variety of stigmata associated with the CNS have been described in patients with NFl . For example, CNS tumors (optic gliomas) occur in up to 30% of children affected with NFl (Huson et al., 1988; Lund and Skovby, 199 1) . Unidentified bright objects, visualized as bright spots in gadolinium-enhanced magnetic resonance imaging (MRI), are detected in the brains of 30-60% of patients; these may be small harmatomas (Duffner et al., 1989; Mulvihill et al., 1990) . NFl patients are also prone to a variety of mental deficits; 30-50% have specific disorders of cognition and memory (Dunn and Roos, 1988; Eldridge et al., 1989 ). In addition, many patients exhibit clumsiness (Dunn and Roos, 1988) . The etiology of these significant and often disabling CNS manifestations is not known. The gene that confers predisposition to NFl was recently cloned and its cDNA sequenced Wallace et al., 1990; Marchuk et al., 199 1) . Mutations in the NFl gene have been defined in some patients Viskochil et al., 1990; Wallace et al., 1990) . Of the 28 18 amino acids in the protein, a region of approximately 360 amino acids is homologous to mammalian GTPase activating protein (GAP) Xu et al., 1990a) , which stimulates the intrinsic GTPase activity of ras-p2 1. A fragment of neurofibromin containing the NFl GAP-related domain (NFl-GRD) binds to and stimulates the GTPase activity of N-ras (Martin et al., 1990 ) and H-ras (Ballester et al., 1990) as do yeast IRA proteins (Tanaka et al., 1990a,b) and GAP itself . This suggests that the homology between neurofibromin and GAP proteins has functional significance. This is further supported by the finding that introduction of NFl -GRD into IRA-deficient yeasts, which are incapable of cell division, complements these strains and restores normal proliferation (Ballester et al., 1990; Xu et al., 1990b) . Ras initiates growth and/or differentiation signals in several cell types including neurons and glial cells (Bar-Sagi and Feramisco, 1985; Noda et al., 1985; Guerrero et al., 1986; Hagag et al., 1986; Ridley et al., 1988; Borasio et al., 1989) . Ras is present in the CNS (Furth et al., 1987) . Taken together, these findings suggest that neurofibromin may play a role in the regulation of ras or ras-like proteins in neurons and glia, as well as other cell types.
Insights into the function of neurofibromin and the etiology of the CNS manifestations of NFl may be provided by knowledge of the neuroanatomical distribution and the types of cells expressing neurofibromin in the normal brain. We and others have previously shown that neurofibromin is a 220 kDa protein highly enriched in the brain and spinal cord of adult rats (Hattori et al., 199 1; Daston et al., 1992) . Others have demonstrated that neurofibromin is expressed in the mouse brain Gutmann et al., 199 1) . Within the spinal cord of both rat and human, neurofibromin is present in neurons and oligodendrocytes, but not in astroglial or microglial cells (Daston et al., 1992) . The localization of neurofibromin in the brain is unknown. Thus, we have investigated the cellular, subcellular, and neuroanatomic distribution of neurofibromin in the adult rat brain. We show, for the first time, that neurofibromin is expressed preferentially in the dendrites of long-projection neurons, where it is localized to stacks of smooth membranous cisterns thought to be involved in Ca*+ regulation, and to small vesicles and multivesicular bodies that may be part of the endocytic pathway.
Materials and Methods
Preparation of antibodies. Polyclonal antibodies recognizing two TrpE fusion nroteins containing amino acids 772-1085 or 2435-2745 of the human^NFl sequence (nomenclature according to Marchuk et al., 199 1) have been described previously (Daston et al., 1992) . The same fusion proteins were injected at monthly intervals into Balb/C mice (30 & mouse/injection). Three days after the fourth injection, the spleens were surgically removed from the mice and the splenocytes isolated and fused with P3X/63 Ag8.653 myeloma cells using standard protocols (Kohler and Milstein, 1976) . Hybridomas were grown on 96-well plates under hypoxanthine aminopterin thymidine (HAT) selection. After 2 weeks, conditioned media from each well were assayed by an Elisa (Daston et al., 1992) . Cells in wells that recognized the appropriate fusion protein more strongly than the inappropriate fusion protein or vector proteins were cloned by dilution. One antibody recognizing each fusion protein was cloned an additional time. Monoclonal antibodies were not useful for immunoprecipitation or Western blotting, but were used in immunostaining.
Zmmunoprecipitation. Extracts of cortex, medulla, pons, cerebellum, and diencephalon were made by surgically dissecting adult rat brains into these regions and homogenizing the regions in buffer containing 0.1% SDS and 1% Triton X-100 (TXlOO) (Daston et al., 1992) . Immunoprecipitation of neurofibromin from 1 mg of total protein, electrophoresis, and Western blot analysis were performed as previously described (Daston et al., 1992) .
Preparation of tissue. Adult rats, 250-350 gm, were anesthetized with sodium pentobarbital and intracardially perfused at 80-100 ml/min with room temperature 0.9% NaCl until clearing of the liver was observed (100-200 ml) and then with 1 liter of 4% paraformaldehyde, 0.1% glutaraldehyde, and 0.2% picric acid in 0.1 M NaPO,, pH 7.4 (PB) at 4°C. Following perfusion, brains were surgically removed and placed in ice-cold perfusion fixative ( 100-200 ml/brain) for 4-24 hr. Postfixed brains were cryoprotected by equilibration in 20% sucrose in PB at 4°C for 24 hr and then into cold 30°h sucrose in PB. Brains were stored at 4°C in 30% cryoprotectant containing 0.02% NaN, for up to 2 weeks.
Zmmunohistochemistry. A total of 14 brains cut in coronal section, 2 in sagittal section, and 3 in horizontal section were evaluated. Fixed, cryoprotected brains were frozen and serially sectioned at 30-40 pm on a sliding microtome; every third section was analyzed. The sections were rinsed in PB and then blocked overnight in 10% normal goat serum or 10% horse serum in PB containing 0.4% TX 100. To minimize nonspecific interactions of the antibodies, primary antibodies were diluted in blocking buffer containing 10 &ml of bacterial protein extracts, prepared from bacteria transfected with vectors containing the fusion protein sequence in an antisense orientation. Primary antibodies were then applied for 48 hr; polyclonal antibodies were used at a concentration of 1 &ml, and monoclonal antibodies were prepared by concentrating conditioned media lo-fold in a Centricon 30 microconcentrator (Amicon, Danvers, MA). Sections were then incubated in 0.5% H,O, for 10 min and washed five times in PB with T&on. Biotinylated goat anti-rabbit or horse anti-mouse secondaries (Vector Labs, Bbrlingme, CA) were diluted 1:250 in blocking buffer and applied for 4 hr at room temperature on an orbital shaker. Samples were washed three times, and staining was visualized with standard HRP methods using a Vectastain kit (Vector Labs, Burlingame, CA).
Immunoelectron microscopy. Adult rats were fixed by perfusion as above, except that glutaraldehyde was increased to 0.2% and fixative was at room temperature. After sucrose infiltration, 50 pm sections of cerebellum were cut on a freezing microtome, washed in 0.1% TX100 in PB for 15 min, 0.1 M glycine for 30 min, 0.5% H,O, in 0.1% TX 100 in PB for 15 min, 0.1% TX100 in PB for 15 min, and 10% normal goat serum in PB for 1 hr, and then stained as above for neurofibromin, using a polyclonal antibody recognizing amino acids 2435 -2745 [PC (2435 -2745 ]. Reactions were controlled using a glucose-oxidase kit (Sigma), sections were washed in 0.1% TX 100 in PB and then postfixed in 2% 0~0, in water for 45 min, dehydrated through a graded series of alcohols, and flat embedded in Epon 8 10. Semithin (1 pm) sections were taken until reaction product became visible, and then silver gray sections were analyzed on Formvar-coated grids in a JOEL 100 electron microscope at 60 kV. Figure 1 . Neurofibromin is expressed throughout the adult rat brain. Detergent extracts from major anatomical regions of adult rat brain were immunoprecipitated using PC (2435-2745). Precipitated protein was electrophoresed and visualized by Western analysis using PC (772-1085). Lanes: I, cerebellum; 2, medulla; 3, pons; 4, midbrain; 5, diencephalon; and 6, cortex. A single 220 kDa protein was precipitated from all regions, indicating that neurofibromin is distributed throughout the brain. The apparent molecular weight of neurofibromin has previously been estimated at 220 kDa (Daston et al., 1992) . The similar intensities of the bands suggest that the amount of neurofibromin per milligram of protein is constant throughout the major regions of the brain.
Results
Regional distribution of neurojibromin in the rat brain Adult rat brains were dissected into cortex, diencephalon, cerebellum, midbrain, pons, and medulla. Detergent extracts of each sample were prepared and neurofibromin immunoprecipitated using PC (2435-2745). Precipitated protein was analyzed by Western analysis using a second polyclonal antibody, PC (772-1085). The specificity of these antibodies has been demonstrated previously (Daston et al., 1992) . As illustrated in Figure 1, a single 220 kDa band was observed in all brain regions. The relative abundance of neurofibromin per milligram of extracted protein was similar for all the major anatomical subdivisions of the brain; the abundance of neurofibromin in the brain has been shown to be 0.004% of total protein (Daston et al., 1992) .
Immunohistochemical localization of neurojibromin in the adult rat brain
We used two polyclonal antibodies as well as two monoclonal antibodies raised against two different domains of neurofibromin (Daston et al., 1992) to stain adult rat brain sections. All antibodies gave similar staining patterns, but the most robust staining was observed with PC (2435-2745). Figure 2 shows an example of staining of layer V in the rat cerebral cortex using the two monoclonal antibodies (Fig. 2E ,F) and PC (2435-2745) ( Fig. 2A,D) . Staining was abolished when the antibodies were preabsorbed with their appropriate fusion protein; an example of staining following preabsorption of PC (2435-2745) is shown in Figure 2B . Use of preimmune sera resulted in nonspecific staining of the sections, which was not diminished in intensity when preabsorbed with either fusion protein (not shown). Because of the similarity of the staining patterns of the three antibodies raised against two different domains of neurofibromin, we conclude that the staining pattern reflects the authentic distribution of neurofibromin.
Cerebral cortex
The most prominent neurofibromin staining in cerebral cortex was in apical dendrites of pyramidal cells. The thicker dendrites of the largest pyramidal cells, those in layer V, showed the most intense staining (Fig. 2C) . The entire length of the apical dendrites could be visualized as they coursed toward the pial surface. Apical dendrites give rise to smaller dendrites that project laterally and are called oblique branches; these easily identifiable higher-order branches were less intensely stained than the thicker primary dendrites. A meshwork of fine processes coursing throughout all layers of cortex was also observed. These fine processes were densest in layers I, II, and III (Fig. 2C) , and had the characteristic organization of the terminal tufts of apical dendrites. Fine processes were also stained in layers IV and V. These may be oblique branches of apical dendrites from pyramidal cells in layers IV and V and/or basal dendrites of neurons in these or more superficial layers. Stained basal dendrites could only be traced 30-50 pm from their point of origin on the neuronal cell body, although they project an average of 185 pm (Winkelmann et al., 1973) in rat layer V neurons.
Neurofibromin expression was also observed in the perikaryon of pyramidal neurons (Fig. 2C,D) surrounding the large unstained nucleus. The large (30-50 pm in diameter) pyramidal neurons, of layer V, were the most intensely stained (Fig. 2D ), but significant staining of pyramidal neurons with smaller (lo-25 pm in diameter) cell bodies in all other layers was also observed (Fig. 2C) .
The piriform cortex and hippocampus, examples of archeocortex, also showed prominent neurofibromin immunoreactivity. As in the neocortex, staining was entirely restricted to the dendrites and perikarya of pyramidal neurons, was most prominent in the apical dendrites and cell bodies, and was present in fine distal dendrites.
Neurofibromin is preferentially expressed in the dendrites of neuronal subsets. In the CA fields in the hippocampus, staining was enriched in the apical dendrites of pyramidal cells (Fig.  3A) . In sharp contrast, the granule cells of the dentate gyrus, which elaborate an extensive dendritic array in the dentate molecular layer, exhibited little dendritic neurofibromin staining (Fig. 3B ). Multipolar neurons, presumably basket cells (interneurons), deep to the pyramidal cell layer in Ammon's horn were stained.
Thalamus, basal ganglia, and brainstem Many neurons were stained in the brainstem, basal ganglia, and thalamus; most nuclei contained immunoreactive neurons; examples are shown in Figure 4 . Stained neurons ranged in size from 10 to 50 Km in diameter and possessed a multipolar morphology. As in the neocortex and hippocampus, staining was enriched in cell bodies and processes emanating from cell bodies.
Not all neurons within subcortical nuclei were stained. In several thalamic nuclei, the percentage of unstained neurons was estimated in cresyl violet-counterstained sections; neurons were identified by the presence of euchromatic nuclei with prominent nucleoli. The majority of neurons demonstrated neut The Journal of Neuroscience, April 1993, f3(4) 1591 rofibromin immunoreactivity, but 30% were unstained. Thus, as in the cortex, only a subpopulation of neurons expressed neurofibromin.
Hypothalamus
The cell bodies of neurons in most hypothalamic nuclei were unstained; unstained nuclei included the paraventricular, ventromedial, and suprachiasmatic nuclei as well as all the nuclei in the lateral hypothalamic area (not shown). The only nucleus that contained immunostained neurons was the supraoptic nucleus, in which staining was restricted to cell bodies and dendrites of most, if not all, neurons. The majority of the staining in the hypothalamus was of fine processes in the neuropil in the periventricular and lateral hypothalamic areas. Throughout these areas, weakly stained neuronal cell bodies were occasionally observed; stained neurons were not clustered and their positions did not correspond to known cytoarchitectonic boundaries.
Cerebellum
In the deep nuclei of the cerebellum, large neurons with cell bodies 25-50 pm in diameter were heavily stained (Fig. 5C ).
The staining was restricted to the cell body and proximal processes. Some of the processes originating from these neurons may be axons. Multiple processes extend from each cell soma, however, and therefore, at least the majority of processes are dendrites. Not all the neurons in the deep nuclei were stained. Counterstaining with cresyl violet revealed neurons, as identified by the presence of euchromatic nuclei with prominent nucleoli, which contained no neurofibromin immunoreactivity (Fig.  5D ). Approximately 70% of neurons showed prominent neurofibromin staining; 30% were not detectably reactive. Glial and endothelial cells identified by small, highly heterochromatic nuclei were not stained by anti-neurofibromin antibodies. Neurofibromin staining in the cerebellar cortex was highly enriched in the cell bodies and dendrites of the Purkinje cells, the output neurons of the cerebellum. The majority of the extensive dendritic arbor of the Purkinje cells was intensely stained in sections cut perpendicular to the pial surface (Fig. 5A,B) . Primary, secondary, tertiary, and quatemary branches of the dendrites were stained, but the fine terminal branches were not detectably labeled. Neurofibromin immunoreactivity was also observed in the cell bodies of the Purkinje cells; the staining was homogeneous over the entire cell body except for the nucleus, which was clear. The proximal 50 pm of Purkinje cell axons demonstrated weak reactivity. Occasionally, the cell body and dendrites of Golgi neurons in the granular layer were weakly stained. A meshwork of fibers surrounding granule cells was very weakly reactive in some preparations, suggesting that granule cell dendrites may contain some neurofibromin. Other neuronal cell types in the cerebellum including basket and stellate neurons located between the monolayer of the Purkinje cells and the pial surface were unstained. 
Glia
Neurofibromin immunoreactivity is prominent in oligodendrocytes in the adult rat spinal cord (Daston et al., 1992) . Oligodendrocytes were also stained in the brain (not shown). There was no evidence of neurofibromin immunoreactivity in astrocytes, micro&a, or endothelial cells anywhere in the brain.
Axons
The majority of axons were stained in the brain. For example, weakly stained axons were observed as they originated from Purkinje cell bodies in the cerebellum (Fig. 4B) , and axons were stained in white matter tracts (not shown). The axonal staining was always less intense than that observed in cell bodies and in dendrites; in many tracts axonal staining could be detected only in thin (2 pm) sections.
Ultrastructural localization of neurofibromin
To define the subcellular localization of neurofibromin, preembedding immunoperoxidase electron microscopy was carried out. The cerebellum was selected for analysis since the most robust staining at the light microscope level was detected in Purkinje cells. Figure 6A shows low-magnification electron micrographs of the cell body and proximal dendrite of a Purkinje cell stained by anti-neurofibromin, in which reaction product is visible in small patches in the cell body and is intense in the proximal dendrite. Even at low magnification, it was evident that the plasma membrane, nuclear envelope, mitochondria, and rough endoplasmic reticulum were not detectably stained. No reaction product was detected when antibody was preabsorbed with fusion protein prior to staining (Fig. 6B) .
At higher magnification, reaction product was observed on tubulovesicular profiles and membranous stacks in the cell body (Fig. 7,4-C) . These profiles are characteristic of the smooth endoplasmic reticulum of Purkinje cells (Rosenbluth, 1962; Morales and Duncan, 1966; Takahashi and Wood, 1970) . Reaction product was not associated with the plasma membrane, nuclear membrane, Golgi apparatus, or rough endoplasmic reticulum (not shown). Some staining of mitochondria was seen, but only when adjacent to heavily labeled cisternal stacks or membrane vesicles (Fig. 7C) ; this was most likely diffused from nearby membrane stacks.
Reaction product in dendrites was so heavy as to obscure identification of labeled structures. To analyze the staining of dendritic organelles, semiserial sections were analyzed. At progressively deeper levels of each block, staining diminished and it became possible to detect specific staining of cisternal stacks (Fig. 7E) . For comparison, a proximal dendrite from a section stained with preabsorbed antibody is shown in Figure 7F . In stained dendrites, some cistemal stacks were stained heavily and others appeared less intensely stained or unlabeled (Fig.  7C ). Vesicles and multivesicular bodies were sometimes, but not always, stained. In addition to staining of membranous cisterns, multivesicular bodies, and small vesicles, diffuse staining of the cytoplasm, cytoskeleton, and mitochondria was observed. This may be a product of diffusion of the reaction product, or may represent the presence of a pool of soluble neurofibromin in dendrites.
Discussion

Neurojibromin in neurons
Our results support the hypothesis that the primary defect that leads to the development of the diverse CNS manifestations of type 1 neurofibromatosis is in the neuron. The subset of neurons intensely labeled by anti-neurofibromin antibodies does not appear to correlate with the distribution of any of the major neurotransmitters, or with a particular sensory or motor system. Rather, neurofibromin is expressed primarily in large neurons whose axons project long distances. For example, in the cerebellum, only Purkinje cells were heavily stained with anti-neurofibromin antibodies. Similarly, only pyramidal cells were stained in the cortex; nonpyramidal and stellate cells were unstained. However, rare interneurons also express neurofibromin; these include occasional Golgi cells of the cerebellum and hippocampal neurons deep to pyramidal cells, which have the morphology of basket cells. In the thalamus, basal ganglia, and brainstem, neurofibromin was also expressed by only subpopulations of neurons; the neurons labeled in these regions may be mainly those that project axons long distances. Based on the staining patterns in the cortex and cerebellum, where the cytoarchitecture and basic circuitry have been definitively established, it seems plausible that stained neurons in the thalamus, basal ganglia, and brainstem are mainly projection neurons rather than interneurons. Further evaluation of this hypothesis will require double labeling with anti-neurofibromin and retrograde tracers.
NFl patients often exhibit learning disabilities and clumsiness. Intense neurofibromin staining is present in the cortex and hippocampus, structures involved in cognition and memory, and in the cerebellum, the structure responsible for coordination of motor movements. Defects in output neurons have the greatest potential to disrupt the normal function of specific brain regions because these neurons are the nodal points for information flow out of these regions. Output neurons receive integrated synaptic inputs and transmit an appropriate response. Thus, it is reasonable that NFl patients who have only one normal NFl allele might exhibit CNS dysfunction. While these inferences are currently highly speculative, they may provide working hypotheses for future investigations of specific brain areas in NFl -affected individuals and normal human controls.
Ultrastructural analysis of neurojibromin distribution
Light microscopic analysis suggested that neurofibromin was primarily expressed by neurons in the CNS. Large, presumably projection neurons were the most heavily stained, and in the majority of neurofibromin-positive neurons, staining was preferentially heavy in dendrites. This suggests that neurofibromin is selectively enriched in dendrites of CNS projection neurons. At the ultrastructural level, neurofibromin is preferentially associated with smooth endoplasmic reticulum and multivesicular bodies. These organelles are present in all compartments of neurons-soma, axon, terminals, and dendrites. Based on these findings, it is possible that the preferential staining of dendrites of large neurons observed at the light microscope level is the result of large neurons and dendrites having a higher absolute content of smooth endoplasmic reticulum and thus of neurofibromin. The apparent lack of neurofibromin in many neurons and in small dendritic processes may reflect a relatively lower concentration of these membranes rather than a specificity of neurofibromin for large neurons. To date our ultrastructural observations are limited to Purkinje cells. In future studies it will be necessary to examine small neurons and fine-caliber neuronal processes to determine if neurofibromin is present. For the present it is safe to say that neurofibromin is selectively enriched in large neurons. Whether this reflects specificity or a concentration effect remains to be determined.
Our ultrastructural results indicate that neurofibromin is preferentially associated with intracellular membranes. Several groups have carried out subcellular fractionation to localize neurofibromin. The results of these studies have been inconclusive, in that while some have found neurofibromin entirely membrane bound (DeClue et al., 199 1; Hattori et al., 1991) others have found neurofibromin in both membrane and cytosolic fractions (Bollag and McCormick, 1991) . Under the conditions of fixation and permeabilization used in our study, soluble neurofibromin might be removed from sections and thus not detected, or be present at levels too low to be detected in the cell body of Purkinje cells. It is also possible that some of the diffuse staining in dendrites might reflect the presence of soluble neurofibromin.
Functional implications of neurojibromin localization
Neurofibromin immunoreactivity was not associated with the plasma membrane. This result was surprising, since it has been shown that neurofibromin can modulate the activity of ras (Ballester et al., 1990; Martin et al., 1990 ), and ras is targeted i Figure 7 . Ultrastructural localization of neurofibromin in the cell body and dendrites of Purkinje cells. Peroxidase reaction product covers membranous elements in the cell body (A-C) and dendrite (E). No reaction product is present in section preabsorbed using fusion protein (0, F). In each panel, cistemal stacks are indicated by large arrows and small arrowheads point to vesicles and tubulovesicular membranes. In C, the large arrowhead points to a stained multivesicular body and the paired small urrows to stained (right) and unstained (left) membrane stacks. Scale bar, 0.3 firn.
to the plasma membrane (Willingham et al., 1980; Hancock et proteins that are not in the ras superfamily, or that it interacts al., 199 1). Our data thus suggest that, in neurons, neurofibromin with ras-like proteins that are not plasma membrane associated. may not interact with plasma membrane associated ras-p21.
Alternatively, under certain conditions neurofibromin might be This might be because in neurons neurofibromin interacts with targeted to the plasma membrane, where it could interact with t Figure 6 . Ultrastructural localization of neurofibromin in Purkinje cells. Preembedding immunoperoxidase staining of sections of cerebellum with PC (2435-2745) shows dark reaction product in the electron micrograph showing the cell body and proximal dendrite of a Purkinje cell (A). Arrows delineate the unstained plasma membrane. Mitochondria (m) are also unstained, as is the nucleus (n), nuclear envelope (ne), and rough endoplasmic reticulum (rer). Surrounding neuropil is also unstained (* (Quinn et al., 1992) and, following activation, the ras-related molecule RAP 1 B translocates from membranes (probably the plasma membrane) to the cytoskeleton (Fischer et al., 1990) . Since ras activation leads to proliferation in some cell types and differentiation in others, such as neurons, our results do not preclude the possibility that neurofibromin will show a distinct pattern of localization in non-neural cells or immature neurons.
The membranous stacks labeled by anti-neurofibromin in the cell body and in dendrites of Purkinje cells have been described as multilaminated bodies (Morales and Duncan, 1966 ) lamellar bodies (Hemdon, 1964) , and cistemal stacks (Villa et al., 199 1) . These stacks of smooth endoplasmic reticulum are often found in close proximity to mitochondria (Takahashi and Wood, 1970; Fiori and Mugnaini, 1981) ; at least some are continuous with the rough endoplasmic reticulum (Hemdon, 1963; Satoh et al., 1990) and they are enriched in proximal dendrites (Yamamoto et al., 199 l) , as is neurofibromin immunoreactivity. There are no clues as to why smooth endoplasmic reticulum in Purkinje cells form stacks; stack number can be altered by changes in fixation or damage (see references in Takei et al., 1992) .
Cistemal stacks have been previously shown to contain components of the Ca2+ regulatory system in Purkinje cells Satoh et al., 1990; Villa et al., 1991) . Extracellular signals are thought, through the action of second messengers, to induce the release of Ca2+ from intracellular Ca2+-rich compartments . One constituent of this system is the inositol 1,4,5-triphosphate (IP3) receptor, which is concentrated in the Purkinje cell of the cerebellum, and within these cells is enriched in smooth-surfaced cistemae (Ross, 1989; Otsu et al., 1990; Villa et al., 1991; Walton et al., 1991; Yamamoto et al., 1991; Takei et al., 1992) .
The association of neurofibromin with smooth endoplasmic reticulum raises some intriguing questions about the function of neurofibromin. G-proteins, including ras-p2 1, can regulate certain types of ion channels (Dolphin et al., 1989; Brown and Bimbaumer, 1990; Collin et al., 1990; Yatani et al., 1990) . For example, active GTP-bound ras is essential for the release of Ca*+ from intracellular stores in NIH-3T3 cells (Lloyd et al., 1989; Maly et al., 199 1) . Since neurofibromin can increase the hydrolysis of GTP by ras, we hypothesize that neurofibromin might indirectly modulate intracellular Ca*+ levels within brain neurons from its position in cistemal stacks. It will be of interest to determine if neurofibromin colocalizes with one or more Ca2+ regulatory proteins in the Purkinje cell. Gutmann and Collins (1992) showed by immunofluorescence that neurofibromin roughly colocalized with microtubules in cultured cell lines. Our results may explain this observation, since endoplasmic reticulum is present in close association with microtubules (Terasaki et al., 1986; Cheng and Reese, 1988; Price et al., 199 1) . Binding of endocytic vesicles to microtubules is regulated by both ATP and GTP (Scheel and Kreis, 1992) . G-proteins in the ras superfamily are distributed in association with organelles throughout the endocytic and exocytic pathways (Balch, 1990) . In addition, molecular motor proteins such as kinesin, dynein, and dynamin are thought to mediate transport of membrane-bounded organelles along microtubules. These proteins localize to intracellular vesicles in immunostaining experiments (Pfister et al., 1989; Scaife and Margolis, 1990) . Dynamin is a potent GTPase; kinesin also contains a GTP-binding consensus sequence (Obar et al., 1991; Shpetner and Vallee, 1992) . Neurofibromin, by regulating the amount of GTP bound to G-proteins, could provide a link between G-proteins and organelle movement.
